Skip to main content

Loading market data...

OSCR

Oscar Health, Inc.

NYSE • United states

$33.45

-$0.21

(-0.62%)

Source: Yahoo Finance · Quote time Oct 21, 2026 20:00 GMT+0000

Management
Credibility
Score

Oscar Health, Inc. (OSCR)

Unavailable

Quotes may be delayed

$10.32B

Market Cap

3,293,997

Volume

18.7

P/E Ratio

Unavailable

Div Yield

Oscar Health, Inc. Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: 75 VARICK STREET, NEW YORK, NY
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

19 Sep 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Oscar Health, Inc..

16 Sep 2026

Oscar Health, Inc. reported Regulation FD disclosure

Oscar Health, Inc. filed an 8-K covering Regulation FD disclosure.

7 Aug 2026

Oscar Health, Inc. filed Form 10-Q

Oscar Health, Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

6 Aug 2026

Oscar Health, Inc. reported Operating or financial results

Oscar Health, Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.

10 Jun 2026

Oscar Health, Inc. reported Shareholder voting results

Oscar Health, Inc. filed an 8-K covering shareholder voting results.

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$4.08B

Total assets (USD)$11.23B

Total liabilities (USD)$9.17B

Shareholders' equity (USD)$2.05B

Long-term debt (USD)$431.63M

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 30 Jun 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$6.10M	$388.64M	$361.81M	$1.10	10-Q · 7 Aug 2026
Q1 2026	$5.72M	$704.09M	$679.00M	$2.07	10-Q · 7 May 2026
Q4 2025	$8.97M	−$333.75M	−$352.61M	Unavailable	10-K · 13 Feb 2026
Q3 2025	$8.80M	−$129.25M	−$137.45M	−$0.53	10-Q · 6 Nov 2025
Q2 2025	$6.50M	−$230.48M	−$228.36M	−$0.89	10-Q · 7 Aug 2025
Q1 2025	$4.33M	$297.12M	$275.27M	$0.92	10-Q · 8 May 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Neutral

Target: $35.78

7.0% upside potential

📈

Strong Buy

Unavailable

👍

Buy

3

⏸️

Hold

6

📉

Sell

1

10 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 22 Oct 2026, 02:50 UTC Targets range 27.00–49.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

18

Sep 2026

WITTMAN VANESSA AMES

Director

Open-market sale

$32.24 per share

25,000 shares

18

Sep 2026

Kushner Joshua

Director, Co-Founder and Vice Chairman

Other

Unavailable per share

19,030,851 shares

18

Sep 2026

Thrive Partners II GP, LLC

Director

Other

Unavailable per share

19,030,851 shares

3

Sep 2026

Liang Janet

President, Oscar Insurance

Open-market sale

$31.45 per share

10,360 shares

3

Sep 2026

Baltrus Victoria

Chief Accounting Officer

Open-market sale

$31.45 per share

958 shares

Top Shareholders

Vanguard Group Inc

20,701,250 shares

2.683% change

12/31/2025

Blackrock, Inc.

20,587,428 shares

18.937% change

6/30/2026

T. Rowe Price Investment Management, Inc.

13,035,486 shares

11.945% change

6/30/2026

D. E. Shaw & Co., Inc.

12,643,617 shares

130.501% change

6/30/2026

Vanguard Portfolio Management Llc

11,029,424 shares

4.585% change

6/30/2026

Vanguard Capital Management Llc

10,579,437 shares

-1.839% change

6/30/2026

American Century Companies Inc

9,055,242 shares

28.82% change

6/30/2026

Jane Street Group, Llc

6,365,039 shares

119.174% change

6/30/2026

Thrive Capital Management, Llc

6,343,617 shares

0% change

6/30/2026

Geode Capital Management, Llc

5,819,186 shares

15.638% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 22 Oct 2026, 02:50 UTC· 5 hours ago

Research coverage and investment tools

Oscar Health, Inc. (OSCR) is a stock listed on the New York Stock Exchange in the United States, in the Health Care sector (Medical Specialities). Its last price was US$33.45 on 21 Oct 2026. That is 94% of the way from its 52-week low of US$10.69 to its 52-week high of US$35.01. Its market capitalisation was US$10.32 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$6.10M	$388.64M	$361.81M	$1.10	—	6,376.3%	—	10-Q · 7 Aug 2026 (opens in a new tab)
Q1 2026	$5.72M	$704.09M	$679.00M	$2.07	—	12,313.5%	—	10-Q · 7 May 2026 (opens in a new tab)
Q4 2025	$8.97M	−$333.75M	−$352.61M	Unavailable	—	-3,722.8%	—	10-K · 13 Feb 2026 (opens in a new tab)
Q3 2025	$8.80M	−$129.25M	−$137.45M	−$0.53	—	-1,468.6%	—	10-Q · 6 Nov 2025 (opens in a new tab)
Q2 2025	$6.50M	−$230.48M	−$228.36M	−$0.89	—	-3,547.5%	—	10-Q · 7 Aug 2025 (opens in a new tab)
Q1 2025	$4.33M	$297.12M	$275.27M	$0.92	—	6,862.0%	—	10-Q · 8 May 2025 (opens in a new tab)

Quarter ended	Reported	EPS	Consensus	Surprise
Jun 2026	8/6/2026	$1.10	$0.43	+155.8%
Mar 2026	5/6/2026	$2.07	$1.21	+71.1%
Dec 2025	2/10/2026	−$1.24	−$0.84	-47.6%
Sep 2025	11/6/2025	−$0.53	−$0.55	+3.6%

Cash and equivalents: $4.08B
Total assets: $11.23B
Total liabilities: $9.17B
Shareholders' equity: $2.05B
Long-term debt: $431.63M

SCHEDULE 13D/A · 19 Sep 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Oscar Health, Inc..
8-K · 16 Sep 2026

Oscar Health, Inc. reported Regulation FD disclosure (opens in a new tab)

Oscar Health, Inc. filed an 8-K covering Regulation FD disclosure.
10-Q · 7 Aug 2026

Oscar Health, Inc. filed Form 10-Q (opens in a new tab)

Oscar Health, Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.
8-K · 6 Aug 2026

Oscar Health, Inc. reported Operating or financial results (opens in a new tab)

Oscar Health, Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.
8-K · 10 Jun 2026

Oscar Health, Inc. reported Shareholder voting results (opens in a new tab)

Oscar Health, Inc. filed an 8-K covering shareholder voting results.

Insider	Date	Transaction	Shares	Average price	Filing
WITTMAN VANESSA AMES Director	18 Sep 2026	Open-market sale (S)	−25,000	$32.24	Form 4 (opens in a new tab)
Kushner Joshua Director, Co-Founder and Vice Chairman	18 Sep 2026	Other (J)	−19,030,851	—	Form 4 (opens in a new tab)
Thrive Partners II GP, LLC Director	18 Sep 2026	Other (J)	−19,030,851	—	Form 4 (opens in a new tab)
Liang Janet President, Oscar Insurance	3 Sep 2026	Open-market sale (S)	−10,360	$31.45	Form 4 (opens in a new tab)
Baltrus Victoria Chief Accounting Officer	3 Sep 2026	Open-market sale (S)	−958	$31.45	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Vanguard Group Inc	12/31/2025	20,701,250	2.683%
Blackrock, Inc.	6/30/2026	20,587,428	18.937%
T. Rowe Price Investment Management, Inc.	6/30/2026	13,035,486	11.945%
D. E. Shaw & Co., Inc.	6/30/2026	12,643,617	130.501%
Vanguard Portfolio Management Llc	6/30/2026	11,029,424	4.585%
Vanguard Capital Management Llc	6/30/2026	10,579,437	-1.839%
American Century Companies Inc	6/30/2026	9,055,242	28.82%
Jane Street Group, Llc	6/30/2026	6,365,039	119.174%
Thrive Capital Management, Llc	6/30/2026	6,343,617	0%
Geode Capital Management, Llc	6/30/2026	5,819,186	15.638%

Previous close: 33.66 USD
Day range: 33.05 – 34.28 USD
52-week range: 10.69 – 35.01 USD
Volume: 3,293,997
Market cap: $10.32B
P/E ratio: 18.7
EPS (FY 2025, diluted): −1.69 USD
Shares outstanding: 308.65M
Beta (5Y monthly): 2.49

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 21 Oct 2026, 20:00 UTC· 11 hours ago

Average volume and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 06:14 UTC· 1 hour ago

P/E is market cap ÷ trailing 12-month net income from SEC filings.

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding.

This research is not available for OSCR yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.